|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.3800 - 0.5006|
|52 Week Range||0.1701 - 1.5800|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.00|
Toronto, Ontario--(Newsfile Corp. - February 8, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces that it has been requested by OTC Markets Group Inc. ("OTC Markets") to issue this statement about promotional activity concerning its common stock.On February, 6, 2023, OTC Markets informed the Company that it became aware of ...
Designation Aims to Accelerate Time to Market Toronto, Ontario--(Newsfile Corp. - February 7, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces today the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted Awakn an Innovation Passport as part of the Innovative Licensing and Access Pathway (ILAP) for its proprie
Key Takeaways; Cannabis Sector Green Thumb will have a conference call to discuss its Q4 and full 2022 earnings on February 28, 2023. High Tide Q4 revenue rose 14% to C$108 million. SNDL completed the acquisition of The Valens Company. Columbia Care opened new Cannabist dispensary in Hampton, Virginia. Key Takeaways; Psychedelic Sector Awakn’s lead […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclusive.